A detailed history of Rossmore Private Capital transactions in Novartis Ag stock. As of the latest transaction made, Rossmore Private Capital holds 4,627 shares of NVS stock, worth $455,065. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,627
Previous 4,627 -0.0%
Holding current value
$455,065
Previous $492,000 8.13%
% of portfolio
0.07%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $25,341 - $28,853
266 Added 6.1%
4,627 $447,000
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $127,122 - $144,146
-1,374 Reduced 23.96%
4,361 $440,000
Q1 2023

May 02, 2023

SELL
$80.03 - $92.81 $8,003 - $9,281
-100 Reduced 1.71%
5,735 $527,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $28,709 - $35,157
-380 Reduced 6.11%
5,835 $529,000
Q2 2022

Aug 11, 2022

SELL
$80.52 - $93.75 $402 - $468
-5 Reduced 0.08%
6,215 $525,000
Q1 2022

May 09, 2022

BUY
$80.11 - $90.62 $10,013 - $11,327
125 Added 2.05%
6,220 $546,000
Q4 2021

Feb 07, 2022

BUY
$79.7 - $88.13 $20,722 - $22,913
260 Added 4.46%
6,095 $533,000
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $56,514 - $62,421
663 Added 12.82%
5,835 $532,000
Q1 2021

May 10, 2021

BUY
$83.5 - $98.47 $12,107 - $14,278
145 Added 2.88%
5,172 $442,000
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $206,495 - $249,767
2,645 Added 111.04%
5,027 $475,000
Q3 2020

Nov 10, 2020

BUY
$82.14 - $91.0 $195,657 - $216,762
2,382 New
2,382 $207,000
Q1 2018

May 04, 2018

SELL
$70.39 - $84.15 $76,021 - $90,882
-1,080 Closed
0 $0
Q4 2017

Mar 15, 2018

BUY
$72.33 - $77.64 $78,116 - $83,851
1,080
1,080 $90.7 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.